Indication

Neovascular age-related macular degeneration

Neovascular age-related macular degeneration, commonly referred to as wet or exudative age-related macular degeneration, is an advanced, sight-threatening ocular disorder affecting the central retina in older adults. Read more about Neovascular age-related macular degeneration

21 drugs 15 manufacturers

Advertisement

Drugs that treat it

Common Neovascular age-related macular degeneration therapies.

Showing 19–21 of 21 drugs

Filter & compare in the drug finder →Opens the drug finder with Neovascular age-related macular degeneration preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Neovascular age-related macular degeneration.

Neovascular age-related macular degeneration, commonly referred to as wet or exudative age-related macular degeneration, is an advanced, sight-threatening ocular disorder affecting the central retina in older adults.

It is pathologically characterized by choroidal neovascularization, during which abnormal, fragile blood vessels proliferate from the choroid into the sub-retinal or sub-retinal pigment epithelium spaces.

Exudation from these permeable vessels leads to fluid leakage, intraretinal or subretinal hemorrhage, and progressive fibrovascular scar formation.

These structural changes disrupt the macula, precipitating rapid deterioration of sharp, high-acuity central vision, visual distortion, and the development of central scotomas.

Personalize your experience

Follow Neovascular age-related macular degeneration and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it